NCT05640713 2022-12-07Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) TherapyHenan Cancer HospitalPhase 1 Unknown12 enrolled